Search research articles
Contact Us
Filters
Showing results (1-10 of 4) with videos related to
Page
of 1
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 16, 2021
Immune Profiling Mass Cytometry Assay Harmonization: Multicenter Experience from CIMAC-CIDC
Bita Sahaf, Mina Pichavant, Brian H Lee, et al.
Cancer Cell
|
December 22, 2023
Immune determinants of CAR-T cell expansion in solid tumor patients receiving GD2 CAR-T cell therapy
Sabina Kaczanowska, Tara Murty, Ahmad Alimadadi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 9, 2021
Network for Biomarker Immunoprofiling for Cancer Immunotherapy: Cancer Immune Monitoring and Analysis Centers and Cancer Immunologic Data Commons (CIMAC-CIDC)
Helen X Chen, Minkyung Song, Holden T Maecker, et al.
Neuro-Oncology
|
March 22, 2025
A multi-institutional phase 1 clinical trial exploring upfront multimodal standard of care and combined immunotherapies for newly diagnosed glioblastoma
Patrick Y Wen, Andrea Manzanera, Caroline Duault, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 4) with videos related to
Sort By:
Page
of 1
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 16, 2021
Immune Profiling Mass Cytometry Assay Harmonization: Multicenter Experience from CIMAC-CIDC
Bita Sahaf, Mina Pichavant, Brian H Lee, et al.
Cancer Cell
|
December 22, 2023
Immune determinants of CAR-T cell expansion in solid tumor patients receiving GD2 CAR-T cell therapy
Sabina Kaczanowska, Tara Murty, Ahmad Alimadadi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 9, 2021
Network for Biomarker Immunoprofiling for Cancer Immunotherapy: Cancer Immune Monitoring and Analysis Centers and Cancer Immunologic Data Commons (CIMAC-CIDC)
Helen X Chen, Minkyung Song, Holden T Maecker, et al.
Neuro-Oncology
|
March 22, 2025
A multi-institutional phase 1 clinical trial exploring upfront multimodal standard of care and combined immunotherapies for newly diagnosed glioblastoma
Patrick Y Wen, Andrea Manzanera, Caroline Duault, et al.
Page
of 1